|
US6309669B1
(en)
*
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US6406689B1
(en)
|
1995-10-03 |
2002-06-18 |
Frank W. Falkenberg |
Compositions and methods for treatment of tumors and metastatic diseases
|
|
US5942253A
(en)
*
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
|
CN1126537C
(zh)
*
|
1996-05-23 |
2003-11-05 |
株式会社三养社 |
可局部给药,可生物降解和持续释放的用于治疗牙周炎的药物组合物及其制备方法
|
|
KR0181252B1
(ko)
*
|
1996-12-31 |
1999-03-20 |
박원훈 |
에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법
|
|
US20050074495A1
(en)
*
|
1997-06-17 |
2005-04-07 |
Fziomed, Inc. |
Compositions of polyacids and methods for their use in reducing adhesions
|
|
US20040096422A1
(en)
*
|
1997-06-17 |
2004-05-20 |
Schwartz Herbert E. |
Compositions of polyacids and polyethers and methods for their use in reducing pain
|
|
US7192984B2
(en)
*
|
1997-06-17 |
2007-03-20 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use as dermal fillers
|
|
US6869938B1
(en)
*
|
1997-06-17 |
2005-03-22 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use in reducing adhesions
|
|
DE69831415T2
(de)
*
|
1997-08-29 |
2006-06-29 |
Corixa Corp., Seattle |
Schnellfreisetzende enkapsulierte bioaktive wirkstoffe zur induzierung einer immunantwort und verwendung derselben
|
|
ES2373861T3
(es)
|
1997-09-18 |
2012-02-09 |
Pacira Pharmaceuticals, Inc. |
Composiciones anestésicas liposomiales de liberación sostenida.
|
|
ATE554748T1
(de)
|
1997-11-14 |
2012-05-15 |
Pacira Pharmaceuticals Inc |
Herstellung von multivesikulären liposomen
|
|
US6423345B2
(en)
|
1998-04-30 |
2002-07-23 |
Acusphere, Inc. |
Matrices formed of polymer and hydrophobic compounds for use in drug delivery
|
|
US6730322B1
(en)
|
1998-04-30 |
2004-05-04 |
Acusphere, Inc. |
Matrices formed of polymer and hydrophobic compounds for use in drug delivery
|
|
BR9912070A
(pt)
*
|
1998-07-13 |
2001-04-10 |
Expression Genetics Inc |
Análogo de poliéster de poli-l-lisina como um solúvel, veìculo de distribuição de gene biodegradável
|
|
IL140899A0
(en)
*
|
1998-07-17 |
2002-02-10 |
Skyepharma Inc |
Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
|
|
US6916490B1
(en)
*
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
|
US6284235B1
(en)
*
|
2000-02-11 |
2001-09-04 |
National Starch And Chemical Company Investment Holding Corporation |
Bioadhesive composition
|
|
CA2403962C
(en)
*
|
2000-03-31 |
2009-12-15 |
Kirin Beer Kabushiki Kaisha |
Powdery preparation for transmucosal administration comprising a medicine of high molecular weight and exhibiting an improved storage stability
|
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
US6362308B1
(en)
*
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
|
AU2001283304B2
(en)
*
|
2000-08-11 |
2005-05-05 |
Favrille, Inc. |
Method and composition for altering a T cell mediated pathology
|
|
US6911204B2
(en)
|
2000-08-11 |
2005-06-28 |
Favrille, Inc. |
Method and composition for altering a B cell mediated pathology
|
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
|
EP1328258B1
(en)
|
2000-10-06 |
2008-10-01 |
Pacira Pharmaceuticals Inc |
A controlled-release, parenterally administrable microparticle preparation
|
|
CN101584867A
(zh)
|
2000-10-31 |
2009-11-25 |
瑟莫迪克斯药品公司 |
提高生物活性分子传递的方法和组合物
|
|
DE10055857A1
(de)
*
|
2000-11-10 |
2002-08-22 |
Creative Peptides Sweden Ab Dj |
Neue pharmazeutische Depotformulierung
|
|
AU2002233239B2
(en)
*
|
2000-12-13 |
2006-05-11 |
Merckle Gmbh |
Microparticles with an improved release profile and method for the production thereof
|
|
AU2001298061A1
(en)
|
2000-12-13 |
2003-07-09 |
Purdue Research Foundation |
Microencapsulation of drugs by solvent exchange
|
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
|
US6652886B2
(en)
*
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
|
CN1520313A
(zh)
*
|
2001-05-23 |
2004-08-11 |
������ҩ��ʽ���� |
一种加速骨折愈合的组合物
|
|
ES2427930T3
(es)
|
2001-05-23 |
2013-11-04 |
Mitsubishi Tanabe Pharma Corporation |
Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
|
|
US20030124149A1
(en)
*
|
2001-07-06 |
2003-07-03 |
Shalaby Shalaby W. |
Bioactive absorbable microparticles as therapeutic vaccines
|
|
US20030124196A1
(en)
*
|
2001-08-22 |
2003-07-03 |
Susan Weinbach |
Pulsatile release compositions and methods for enhanced intestinal drug absorption
|
|
US20030083286A1
(en)
*
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
|
CA2497195C
(en)
*
|
2001-12-14 |
2014-07-08 |
The University Of Wyoming |
Methods and compositions for controlled release of drugs
|
|
MXPA04006875A
(es)
*
|
2002-01-18 |
2004-12-06 |
Control Delivery Sys Inc |
Sistema de gel polimerico para suministro controlado de cofarmacos.
|
|
ATE494010T1
(de)
*
|
2002-02-27 |
2011-01-15 |
Pharmain Corp |
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
|
|
US20050260259A1
(en)
*
|
2004-04-23 |
2005-11-24 |
Bolotin Elijah M |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
KR100508911B1
(ko)
*
|
2002-05-09 |
2005-08-18 |
주식회사 펩트론 |
서방성 단백질 약물 제형 및 이의 제조방법
|
|
US7037983B2
(en)
|
2002-06-14 |
2006-05-02 |
Kimberly-Clark Worldwide, Inc. |
Methods of making functional biodegradable polymers
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
US20040141947A1
(en)
*
|
2002-10-16 |
2004-07-22 |
Hunter Samuel F. |
Method for treatment of demyelinating central nervous system disease
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
CN101514223B
(zh)
|
2003-04-11 |
2017-03-01 |
安特里阿比奥有限公司 |
位点特异性蛋白质偶联物的制备方法
|
|
WO2004105799A1
(ja)
*
|
2003-05-29 |
2004-12-09 |
Toudai Tlo, Ltd. |
安定化高分子ミセル
|
|
GB0317999D0
(en)
*
|
2003-07-31 |
2003-09-03 |
Univ Liege |
Improvements in or relating to drug delivery systems
|
|
EP1682571A4
(en)
*
|
2003-10-27 |
2006-12-06 |
Medvet Science Pty Ltd |
BICOORDIN PATTERN AND METHODS OF USE
|
|
EP1586334A1
(en)
*
|
2004-04-15 |
2005-10-19 |
TRASTEC scpa |
G-CSF conjugates with peg
|
|
HRP20110831T1
(hr)
|
2004-04-15 |
2012-01-31 |
Alkermes Pharma Ireland Limited |
Oblik za produljeno oslobađanje na bazi polimera
|
|
ATE491475T1
(de)
*
|
2004-07-16 |
2011-01-15 |
Nektar Therapeutics |
Konjugate enthaltend gm-csf und ein polymer
|
|
EP1674077A1
(en)
*
|
2004-12-27 |
2006-06-28 |
Université de Liège |
Mucoadhesive pharmaceutical compositions comprising chemoattractants
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
US9205046B2
(en)
*
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Enhanced stability of inverse thermal gelling composite hydrogels
|
|
WO2007019331A2
(en)
*
|
2005-08-04 |
2007-02-15 |
Nektar Therapeutics Al, Corporation |
Conjugates of a g-csf moiety and a polymer
|
|
WO2007041190A2
(en)
*
|
2005-09-30 |
2007-04-12 |
The University Of Iowa Research Foundation |
Polymer-based delivery system for immunotherapy of cancer
|
|
US7585675B2
(en)
*
|
2005-11-15 |
2009-09-08 |
University Of Kansas Medical Center |
Inhibition of HIV and SHIV replication with antisense interleukin-4
|
|
AU2006322076C1
(en)
|
2005-12-08 |
2013-11-14 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
|
JP2009520040A
(ja)
|
2005-12-19 |
2009-05-21 |
ファーマイン コーポレーション |
治療薬の送達のための疎水性コアの担体組成物、及び同担体組成物の作製法及び使用法
|
|
ITMI20061545A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
|
MX2009001114A
(es)
|
2006-08-09 |
2009-02-10 |
Intarcia Therapeutics Inc |
Sistemas de suministro osmotico y ensambles de piston.
|
|
EP2131815A4
(en)
*
|
2007-03-22 |
2012-11-07 |
Alkermes Inc |
coacervation
|
|
CN104000779A
(zh)
|
2007-04-23 |
2014-08-27 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
|
US20100196455A1
(en)
*
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
WO2008157540A1
(en)
*
|
2007-06-20 |
2008-12-24 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
|
US7960336B2
(en)
*
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US20090176892A1
(en)
*
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
GB0814302D0
(en)
*
|
2008-08-05 |
2008-10-01 |
Coretherapix Slu |
Compounds and methods
|
|
WO2010085609A2
(en)
*
|
2009-01-23 |
2010-07-29 |
Surmodics Pharmaceuticals, Inc. |
Controlled release systems from polymer blends
|
|
WO2010093452A2
(en)
*
|
2009-02-11 |
2010-08-19 |
University Of Houston |
Reducible polymers for non-viral gene delivery
|
|
KR101233352B1
(ko)
*
|
2009-04-22 |
2013-02-25 |
(주)비씨월드제약 |
유전자 재조합 과립구-대식세포 집락 촉진인자를 함유하는 정제
|
|
CN102458640B
(zh)
*
|
2009-06-05 |
2016-11-23 |
新加坡南洋理工大学 |
多相微粒和生产多相微粒的方法
|
|
EP2450392B1
(en)
|
2009-07-01 |
2014-06-25 |
Japan Science And Technology Agency |
Polyionic dendrimer and hydrogel comprising same
|
|
DK2462246T3
(da)
|
2009-09-28 |
2017-11-06 |
Intarcia Therapeutics Inc |
Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
|
|
EP2498764B1
(en)
|
2009-11-09 |
2017-09-06 |
Spotlight Technology Partners LLC |
Fragmented hydrogels
|
|
CN106913902A
(zh)
|
2009-11-09 |
2017-07-04 |
聚光灯技术合伙有限责任公司 |
多糖基水凝胶
|
|
EP2384759A1
(en)
*
|
2010-05-06 |
2011-11-09 |
Suomen Punainen Risti Veripalvelu |
Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells
|
|
US8546353B2
(en)
|
2010-05-06 |
2013-10-01 |
Glykos Finland Oy |
Compounds and combinations
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
MX369828B
(es)
|
2012-05-21 |
2019-11-22 |
Insmed Inc |
Sistemas para tratar infecciones pulmonares.
|
|
ES2743039T3
(es)
|
2012-11-29 |
2020-02-18 |
Insmed Inc |
Formulaciones de vancomicina estabilizada
|
|
US20170035850A1
(en)
*
|
2014-03-07 |
2017-02-09 |
Reponex Pharmaceuticals Aps |
Compositions for treating lung infections by airway administration
|
|
EP3466432B1
(en)
|
2014-05-15 |
2020-07-08 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
|
WO2016012608A1
(en)
|
2014-07-24 |
2016-01-28 |
Reponex Pharmaceuticals Aps |
Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
WO2020002650A1
(en)
*
|
2018-06-29 |
2020-01-02 |
Targovax Asa |
A formulation
|
|
WO2020066679A1
(ja)
*
|
2018-09-28 |
2020-04-02 |
株式会社カネカ |
樹脂組成物およびその成形体
|
|
DE102019126672B4
(de)
*
|
2019-10-02 |
2021-07-01 |
Universität Rostock |
Wirkstoffdepotsystem sowie Kit zur in situ Polymerisation des Wirkstoffdepotsystems
|
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|
|
KR20230145053A
(ko)
|
2021-01-12 |
2023-10-17 |
듀렉트 코퍼레이션 |
지속 방출 약물 전달 시스템 및 관련 방법
|
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US12151024B2
(en)
|
2021-01-22 |
2024-11-26 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
CN117979970A
(zh)
|
2021-10-14 |
2024-05-03 |
帕西拉制药有限公司 |
布比卡因多囊脂质体制剂及其用途
|
|
US12251468B1
(en)
|
2024-05-20 |
2025-03-18 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US12246092B1
(en)
|
2024-05-20 |
2025-03-11 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US12251472B1
(en)
|
2024-05-20 |
2025-03-18 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|